| Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA J Lucifora, Y Xia, F Reisinger, K Zhang, D Stadler, X Cheng, MF Sprinzl, ... Science 343 (6176), 1221-1228, 2014 | 1079 | 2014 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 843 | 2021 |
| Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes MJ Wolf, A Adili, K Piotrowitz, Z Abdullah, Y Boege, K Stemmer, ... Cancer cell 26 (4), 549-564, 2014 | 726 | 2014 |
| Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV A Stukalov, V Girault, V Grass, O Karayel, V Bergant, C Urban, DA Haas, ... Nature 594 (7862), 246-252, 2021 | 693 | 2021 |
| Living in the liver: hepatic infections U Protzer, MK Maini, PA Knolle Nature Reviews Immunology 12 (3), 201-213, 2012 | 657 | 2012 |
| Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case series MM Böhmer, U Buchholz, VM Corman, M Hoch, K Katz, DV Marosevic, ... The Lancet Infectious Diseases 20 (8), 920-928, 2020 | 558 | 2020 |
| Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection J Lucifora, S Arzberger, D Durantel, L Belloni, M Strubin, M Levrero, ... Journal of hepatology 55 (5), 996-1003, 2011 | 558 | 2011 |
| A global scientific strategy to cure hepatitis B PA Revill, FV Chisari, JM Block, M Dandri, AJ Gehring, H Guo, J Hu, ... The lancet Gastroenterology & hepatology 4 (7), 545-558, 2019 | 487 | 2019 |
| Viral hepatitis and liver cancer M Ringehan, JA McKeating, U Protzer Philosophical Transactions of the Royal Society B: Biological Sciences 372 …, 2017 | 456 | 2017 |
| Not interferon, but interleukin‐6 controls early gene expression in hepatitis B virus infection M Hösel, M Quasdorff, K Wiegmann, D Webb, U Zedler, M Broxtermann, ... Hepatology 50 (6), 1773-1782, 2009 | 416 | 2009 |
| Inflammation and liver cancer: molecular mechanisms and therapeutic targets YM Yang, SY Kim, E Seki Seminars in liver disease 39 (01), 026-042, 2019 | 389 | 2019 |
| Interferon-γ and tumor necrosis factor-α produced by T cells reduce the HBV persistence form, cccDNA, without cytolysis Y Xia, D Stadler, J Lucifora, F Reisinger, D Webb, M Hösel, T Michler, ... Gastroenterology 150 (1), 194-205, 2016 | 366 | 2016 |
| Meyer zum Bueschenfelde, KH, Neuhaus, P. & Gerken, G.(1998) U Protzer-Knolle, U Naumann, R Bartenschlager, T Berg, U Hopf Hepatitis B virus with antigenically altered hepatitis B surface antigen is …, 1998 | 343* | 1998 |
| Immunosurveillance of the liver by intravascular effector CD8+ T cells LG Guidotti, D Inverso, L Sironi, P Di Lucia, J Fioravanti, L Ganzer, ... Cell 161 (3), 486-500, 2015 | 333 | 2015 |
| Hepatitis B virus surface antigen impairs myeloid dendritic cell function: a possible immune escape mechanism of hepatitis B virus ML Op den Brouw, RS Binda, MH Van Roosmalen, U Protzer, ... Immunology 126 (2), 280-289, 2009 | 332 | 2009 |
| Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection C Sarrazin, T Berg, RS Ross, P Schirmacher, H Wedemeyer, U Neumann, ... Zeitschrift fur Gastroenterologie 48 (2), 289-351, 2010 | 319* | 2010 |
| Functional classification of memory CD8+ T cells by CX3CR1 expression JP Böttcher, M Beyer, F Meissner, Z Abdullah, J Sander, B Höchst, ... Nature communications 6 (1), 8306, 2015 | 293 | 2015 |
| T cells expressing a chimeric antigen receptor that binds hepatitis B virus envelope proteins control virus replication in mice K Krebs, N Böttinger, LR Huang, M Chmielewski, S Arzberger, ... Gastroenterology 145 (2), 456-465, 2013 | 274 | 2013 |
| Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern PR Wratil, M Stern, A Priller, A Willmann, G Almanzar, E Vogel, ... Nature medicine 28 (3), 496-503, 2022 | 255 | 2022 |
| Intrahepatic myeloid-cell aggregates enable local proliferation of CD8+ T cells and successful immunotherapy against chronic viral liver infection LR Huang, D Wohlleber, F Reisinger, CN Jenne, RL Cheng, Z Abdullah, ... Nature immunology 14 (6), 574-583, 2013 | 248 | 2013 |
Mathias HeikenwälderUniv. Prof. at Department Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ))dkfz.de의 이메일 확인됨
